EClinicalMedicine 42:101213 Yeh TL et al (2023) Effect of glucagon-like peptide-1 receptor agonists on glycemic control, and weight reduction in adults: a multivariate meta-analysis
Among emerging CKD-protective treatments, finerenone was approved by the FDA in 2021 and was also recommended in the 2022 KDIGO guidelines as first-line therapy for patients with type 2 diabetes who are at high risk of kidney disease progression and cardiovascular events [6, 15]
Every product undergoes our Healf Curation Process
Zhang N, Liu J, Guo R, Yan L, Yang Y, Shi C, Zhang M, Shan B, Li W, Gu J, et al
Step 5: Consider a medication change Persistent, significant injection site reactions that do not respond to technique optimization and source changes may represent individual drug intolerance